Title of article
Doxorubicin-intercalated nano-hydroxyapatite drug-delivery system for liver cancer: An animal model
Author/Authors
Biswanath Kundu، نويسنده , , Debasree Ghosh، نويسنده , , Mithlesh Kumar Sinha، نويسنده , , Partha Sarathi Sen، نويسنده , , Vamsi Krishna Balla، نويسنده , , Nirmalendu Das، نويسنده , , Debabrata Basu، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2013
Pages
10
From page
9557
To page
9566
Abstract
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide, and satisfactory treatment is unavailable. Doxorubicin (DOX) is commonly used for HCC treatment with very limited success and serious side-effects such as cardiotoxicity and non-cancer cell cytotoxicity.
Keywords
Nano-hydroxyapatite , hepatocellular carcinoma , doxorubicin , IN VIVO , HAp-DOX conjugate
Journal title
Ceramics International
Serial Year
2013
Journal title
Ceramics International
Record number
1275398
Link To Document